<!DOCTYPE html><!--[if lt IE 9]>
<html class='lt-ie9 no-js' lang='en'>
<![endif]-->
<!--[if gte IE 9]><!-->
<html class='no-js' lang='en'>
  <!--<![endif]-->
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    <title>Entyvio HCP Engagement - Area Selection</title>
    <meta name="description" content="Media Literacy Council">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link rel="icon" type="image/png" href="/entyvio_hcp/favicon.ico">
    <link rel="stylesheet" href="/entyvio_hcp/assets/styles/main.css">
  </head>
  <body class="page-area-selection"><!--[if lt IE 9]>
<p class='browsehappy'>You are using an <strong>outdated</strong> browser. Please <a href='http://browsehappy.com/'>upgrade your browser</a> to improve your experience.</p>
<![endif]-->
    <header>
      <div class="header">
        <div class="header-wrap">
          <div class="container">
            <div class="logo-wrap hidden"><img class="svg" src="/entyvio_hcp/assets/images/entyvio_logo.svg"></div>
            <div class="navigation-wrap">
              <div class="nav-wrap"></div>
              <div class="home-wrap"></div>
            </div>
          </div>
        </div>
        <div class="menu-overlay"></div>
      </div>
    </header>
    <main>
      <div class="site-wrapper">
        <section class="main-content area-selection">
          <div class="container">
            <div class="section-main">
              <div class="flex flex-col items-center justify-center gap-10 md_flex-row">
                <div class="card-wrap"><a href="/entyvio_hcp/patient-cases">
                    <div class="area-card">
                      <div class="area-card-inner"><img class="area-card-img"
                          src="/entyvio_hcp/assets/images/area-card-patient-cases.svg">
                        <h1 class="area-card-heading">Patient <br> Cases</h1><img class="area-card-btn"
                          src="/entyvio_hcp/assets/images/area-card-btn.svg">
                      </div>
                    </div>
                  </a></div>
                <div class="card-wrap">
                  <div class="area-card area-card-has-modal">
                    <div class="area-card-inner"><img class="area-card-img"
                        src="/entyvio_hcp/assets/images/area-card-quiz.svg">
                      <h1 class="area-card-heading">Quiz</h1><img class="area-card-btn"
                        src="/entyvio_hcp/assets/images/area-card-btn.svg">
                    </div>
                    <div class="profile-details hidden">
                      <div class="profile-details-wrap">
                        <div class="profile-section-wrap">
                          <div class="profile-section">
                            <p class="pt-4 text-sm"> This quiz is based on studies related to Entyvio (vedolizumab) and
                              the prescribing information as approved in your country. The licensed indications of drugs
                              mentioned in this quiz may vary in different countries. Please refer to the prescribing
                              information in your country.</p>
                            <p class="text-sm">This quiz has been initiated, developed and funded by Takeda.</p>
                            <p> <strong>About Entyvio (vedolizumab)</strong></p>
                            <p class="mt-0"> <span style="color: #D04131;">[Placeholder for local country
                                indications]</span></p>
                            <p class="mt-0"> <strong>Entyvio is indicated for the treatment of:</strong></p>
                            <p class="mt-0"><strong>Ulcerative colitis</strong></p>
                            <p class="mt-0 text-sm"> Entyvio (vedolizumab) is indicated for the treatment of adult
                              patients with moderately to severely active ulcerative colitis who have had an inadequate
                              response with, have lost response to, or were intolerant to either conventional therapy or
                              a TNFα antagonist. </p>
                            <p> <strong>Crohn’s disease</strong></p>
                            <p class="mt-0 text-sm"> Entyvio (vedolizumab) is indicated for the treatment of adult
                              patients with moderately to severely active Crohn’s disease who have had an inadequate
                              response with, have lost response to, or were intolerant to either conventional therapy or
                              a TNFα antagonist.</p>
                            <p> <strong>Pouchitis</strong></p>
                            <p class="mt-0 text-sm"> Entyvio (vedolizumab) is indicated for the treatment of adult
                              patients with moderately to severely active chronic pouchitis who have undergone
                              proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis and have had an
                              inadequate response with, or lost response to, antibiotic therapy.</p>
                          </div>
                        </div>
                        <div class="profile-cta">
                          <div class="patient-cta-wrap"><a class="button btn solid purple patient--btn"
                              style="min-width:undefined" href="/entyvio_hcp/quiz/question-1/question" target="_self">
                              <div class="button-wrap"><span class="btn__text">Start</span></div>
                            </a></div>
                        </div>
                        <div class="profile-footnote">
                          <div class="footnote-wrap">
                            <div class="text">TNFα: tumor necrosis factor α. <br>Entyvio (vedolizumab). Summary of
                              product characteristics. Available at:
                              https://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf.
                              Accessed: February 2024.</div>
                          </div>
                          <div class="footnote-logo"><img src="/entyvio_hcp/assets/images/entyvio_logo.svg" width="108"
                              height="36"></div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div><img class="absolute bottom-10 right-16" src="/entyvio_hcp/assets/images/logo-takeda.svg" width="114"
              height="41">
          </div>
        </section>
      </div>
    </main>
    <footer>
      <div class="footer">
        <div class="footer-wrap">
          <div class="container">
            <div class="ref-and-abb-wrap">
              <div class="footer-arrow footer-arrow-prev mobile-only" data-arrow="prev"><img
                  src="/entyvio_hcp/assets/images/arrow_prev.png"></div>
              <div class="footer-btn hidden"><button class="button btn hallow ref-btn" style="min-width:undefined"
                  type="button" aria-label="References & abbreviations">
                  <div class="button-wrap"><span class="btn__text">References & abbreviations</span></div>
                </button></div>
              <div class="footer-arrow footer-arrow-next mobile-only" data-arrow="next"><img
                  src="/entyvio_hcp/assets/images/arrow_next.png"></div>
            </div>
          </div>
        </div>
      </div>
    </footer>
    <div class="modal">
      <div class="modal-overlay"></div>
      <div class="modal-wrap">
        <div class="modal-container">
          <div class="modal-close btn--modal_close close"><img src="/entyvio_hcp/assets/images/close_icon.svg"
              alt="Close">
            <div class="btn_close_circle"></div>
          </div>
          <div class="modal-head"></div>
          <div class="modal-body"></div>
          <div class="modal-footer"></div>
        </div>
      </div>
    </div>
    <div id="nolandscape">
      <div class="mobile-wrap">
        <div class="phone"><svg id="Layer_2" data-name="Layer 2" xmlns="http://www.w3.org/2000/svg"
            viewBox="0 0 476.96 475.16">
            <g id="Layer_1-2" data-name="Layer 1">
              <g>
                <path
                  d="m26.41,293.71c-.5-8.49,2.78-15.4,8.72-21.34C114.57,192.95,194.11,113.63,273.3,33.97c13.11-13.19,31.45-11.84,43.17-.06,41.83,42.07,83.87,83.94,125.79,125.92,13,13.02,12.97,29.49-.17,42.65-79.51,79.58-159.16,159.02-238.5,238.76-11.05,11.1-32.38,10.95-43.14.04-32.42-32.87-65.2-65.37-97.84-98.02-8.96-8.96-17.82-18-26.9-26.84-6.44-6.28-9.8-13.67-9.31-22.72ZM294.85,55.05c-79.68,79.69-159.29,159.31-238.17,238.2,42.01,42.01,84.35,84.36,125.9,125.91,79.11-79.11,158.71-158.73,238.17-238.19-41.72-41.73-83.9-83.91-125.89-125.91Z">
                </path>
                <path
                  d="m258.46,475.16c0-9.03-.12-17.68.14-26.32.03-1.11,1.9-2.96,3.1-3.12,37.74-4.87,70.8-20.66,101.08-42.99,21.99-16.22,41-35.31,55.51-58.59,3.38-5.41,6.01-11.28,8.99-16.95-8.61-9.06-17.09-17.99-25.38-26.72,24.71-24.76,49.37-49.46,73.93-74.06,11.8,99.5-69.23,236.77-217.37,248.75Z">
                </path>
                <path
                  d="m218.51,0c0,8.96-.05,17.44.03,25.93.02,2.46-.75,3.37-3.38,3.7-46.26,5.72-86.6,24.02-120.63,56.24-18.93,17.92-33.93,38.42-44.76,62.13,8.55,9.04,17.02,17.98,25.19,26.62-24.73,24.73-49.41,49.42-73.89,73.9C-10.5,146.96,72.23,11.62,218.51,0Z">
                </path>
              </g>
            </g>
          </svg></div>
        <div class="message">
          <p class="text-center leading-7">Please rotate your device for an<br>optimized user experience</p>
        </div>
      </div>
    </div>
    <script src="/entyvio_hcp/assets/scripts/main.js"></script>
  </body>
</html>
